Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Regulatory Framework for Implantable Neurostimulation Devices: Comparison of Systems in the US and European Union.

PMID: 37306642 · 2024

JournalNeuromodulation : journal of the International Neuromodulation Society
Year2024
PMID37306642

Abstract

Implantable neurostimulation devices must be authorized before they are placed on the market. For this purpose, requirements, and processes for assessing their fulfillment, have been defined in different jurisdictions. In this study, we aimed to address differences between the US and European Union (EU) regulatory systems and their relationship to innovation. A literature review and analysis were conducted using legal texts and guidance documents. The US system has one central body, the Food and

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.